Skip to main content

Effects of Antihypertensive Treatment on Peripheral Flow of the Lower Limbs

  • Chapter
Thrombosis and Cardiovascular Disease

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 164))

  • 89 Accesses

Abstract

The clinical pattern determined in subjects that undergo a high and prolonged pressure regime is defined as “hypertensive disease”.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A. B. Atkinson, J. Brown, A. F. Lever, J. I. S. Robertson, Combined treatment of severe intractable hypertension with Captopril and diuretic. Lancet 8186:105 (1980).

    Article  Google Scholar 

  2. A. B. Atkinson, J. J. Morton, J. Brown, D. L. Davies, R. Fraser, P. Kelly, B. Leckie, A. F. Lever, J. I. S. Robertson, Captopril in clinical hypertension. Changes in componentes of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme. Br.Heart J. 44:290 (1980).

    Article  PubMed  CAS  Google Scholar 

  3. S. A. Atlas, D. B. Case, J. E. Sealey, J. H. Laragh, D. N. McKinstry, Interruption of the renin-angiotensin system in hypertensive patients by Captopril induces sustained production in aldosterone secretion, potassium retention and natriuresis. Hypertension 1:274 (1979).

    Article  PubMed  CAS  Google Scholar 

  4. C. L. Berry, Hypertension and arterial development. Long-term consideration. Br. Heart J. 40:709 (1978)

    Article  PubMed  CAS  Google Scholar 

  5. C. A. Bloxham, D. G. Beevers, J. M. Walker, Malignant hypertension and cigarette smoking. Br.Med.J. 1:581 (1979.

    Article  PubMed  CAS  Google Scholar 

  6. C. Brater, S. Anderson, C. Muckleroy, Effects in normal subjects of long term administration of azosenide. Clin. Pharmacol. Ther. 26:437 (1979).

    PubMed  CAS  Google Scholar 

  7. H. R. Brunner, H. Gavras, B. Waeber, S. C. Textor, G. A. Turini, J. P. Wanters, Clinical use of an orally acting converting enzyme inhibitor: Captopril. Hypertension 2:558 (1980).

    Article  PubMed  CAS  Google Scholar 

  8. C. J. Bulpitt, L. J. Beilin, P. Clifton, C. T. Dollery, G. S. Harper, E. C. Coles, J. S. S. Gear, B. F. Johnson, A. D. Munro-Faure, Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. hypertension care computing project. Lancet 8134:134 (1979).

    Article  Google Scholar 

  9. C. Cavallaro, Modificazioni della parete arteriosa nell’aterosclerosi. In: “Cardiologia d’Oggi”, Vol. 1 p. 193, Mediche Scientifiche, ed., Torino, 1975).

    Google Scholar 

  10. A. W. Jr. Cowley, The concept of autoregulation of total blood flow and its role in hypertension. Am.J.Med. 68:906 (1980).

    Article  Google Scholar 

  11. D. S. Davies, J. L. Reid, Central cardiovascular actions of clonidine. In: “Central Action of Drugs in Blood Pressure Regulation”, The Whitefriers Press, ed., London, (1975).

    Google Scholar 

  12. C. De Mey, D. Wellens, P. M. Vanhoutte, Fisiopathology and pharmacotherapy of occlusive arterial disorders. Angiology 30:433 (1979).

    Article  PubMed  Google Scholar 

  13. A. Ebringer, A. E. Doyle, T. R. Dawborn, Clonidine in the treatment of hypertension. Br. Med. J. 1:402 (1971).

    Article  PubMed  CAS  Google Scholar 

  14. B. Fagrell, Digital pulse plethysmography and digital blood pressure measurement in the evaluation of arterial circulation in the lower limbs. Scand. J. Clin. Lab. Invest. 31:128 (1973).

    Article  Google Scholar 

  15. K. Roger, R. K. Ferguson, H. Peter, J. Vlasses, D. Pharm, R. Janice, R. N. Kojlin, B. S. Anne Shirinian, F. James, J. Burke, C. John, R. Alexander, Captopril in severe treatment-resistant hypertension. Am. Heart J. 99:579 (1980).

    Article  Google Scholar 

  16. S. Forconi, A. Jagenau, M. Guerrini, S. Pecchi, R. Cappelli, Strain-gauge plethysmography in the study of circulation of the limbs. Angiology 30:487 (1979).

    Article  PubMed  CAS  Google Scholar 

  17. W. I. Frishman, S. Halprin, Clinical pharmacology of the new beta-adrenergic blocking drugs. VII. New Horizons in beta-adrenoceptor blockade therapy: Labetalol. Am. Heart J. 98:660 (1979).

    Article  PubMed  CAS  Google Scholar 

  18. H. Gravas, Antihypertensive effects of the oral angiotensin converting-enzyme inhibitor. New Engl. J. Med. 298:991 (1978).

    Article  Google Scholar 

  19. R. M. Greenhangh, D. S. Rosengarten, I. Mervert, B. Lewis, J. S. Colman, P. Martin, Serum lipids and lipoproteins in peripheral vascular desease. Lancet 2:947 (1971).

    Article  Google Scholar 

  20. B. Gribbin, T. G. Pickerilg, P. Sleight, Arterial distensibility in normal and ipertensive man. Clin. Sci. 56:413 (1979).

    PubMed  CAS  Google Scholar 

  21. L. Hansson, S. N. Hunyor, S. Julius, S. W. Hobler, Blood pressure crisis following withdrawal of Clonidine. Am. Heart J. 85:605 (1973).

    Article  PubMed  CAS  Google Scholar 

  22. S. W. Hoobler and E. Sagastume, Clonidine hydrochloride in the treatment of hypertension. Am. J. Cardiol. 28:67 (1971).

    Article  PubMed  CAS  Google Scholar 

  23. W. G. Hughson, J. Mann and A. Garrod, Intermittent claudication: prevalence and risk factors. Br. Med. J. 1:1379 (1978).

    Article  PubMed  CAS  Google Scholar 

  24. K. Hutchinson and H. Williams, Calf blood flow and ankle systolic blood pressure in intermittent claudication monitored over five years. Angiology 29:719 (1978).

    Article  Google Scholar 

  25. R. G. Hutchinson, Medical management of hypertension. Angiology 30:558 (1979).

    Article  PubMed  CAS  Google Scholar 

  26. G. Koch, Haemodynamic effects of combined alpha and beta-adrenoceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise. Br. J. Clin. Pharmacol. 3(Suppl.):725 (1976).

    PubMed  CAS  Google Scholar 

  27. G. Koch, Effetti emodinamici del blocco alfa e beta-recettoriale acuto con somministrazione di labetalolo e.v. e variazioni in corso di trattamento orale protratto in pazienti affetti da ipertensione essenziale. in: “Atti Convegno Venezia”, p.65 (1978).

    Google Scholar 

  28. H. Koffer, P. H. Vlasses, R. K. Ferguson, M. Weiss and A. G. Abler, Captopril in diuretic treated hypertensive patients. J.A.M.A. 244:2532 (1980).

    Article  PubMed  CAS  Google Scholar 

  29. B. O. Kristensen and J. Skork, Captopril or frusemide in drug-resistant hypertension (Letter) Lancet 8196:699 (1980).

    Google Scholar 

  30. D. W. Johns, K. M. Baker, C. R. Ayers, E. D. Vanghau Jr., R. M. Carey, M. J. Peach, M. R. Yancey, E. M. Ortt and S. C. Williams, Acute and chronic effect of Captopril in hypertensive patients. Hypertension 2:567 (1980).

    Article  PubMed  CAS  Google Scholar 

  31. C. L. Johnson, B. P. McGrath, J. A. Miller and P. G. Mathews, Long term effects of Captopril (SQ 14 225) on blood pressure and hormone levels in essential hypertension. Lancet 8141:493 (1979).

    Article  Google Scholar 

  32. P. Lijnen, R. Fagard, J. Staessen, L. J. Verschueren and A. Amery, Dose response in Captopril therapy of hypertension. Clin. Pharmacol. Ther. 28:310 (1980).

    Article  PubMed  CAS  Google Scholar 

  33. G. M. London, M. E. Safar, Y. A. Weiss and A. Simon, Total effective Compliance of the vascular bed in essential hypertension. Am. Heart J. 95:325 (1978).

    Article  PubMed  CAS  Google Scholar 

  34. G. A. McGregor, N. D. Markandu, J. E. Roulston and J. C. Jones, Essential hypertension: effect of an oral inhibitor of angiotensin converting enzyme. Br. Med. J. 2:1106 (1979).

    Article  Google Scholar 

  35. A. Maruyama, T. Ogihara, T. Naka, H. Mikami, T. Hata, M. Nakamaru, K. Iwanaga and Y. Kumahara, Long term effects of Captopril in hypertension. Clin. Pharmacol. Ther. 28:316 (1980).

    Article  PubMed  CAS  Google Scholar 

  36. G. Mattioli, S. Ricci and P. Bertoncelli, Haemodynamics of hypertension. Changes caused by beta blocking agents. Minerva Cardioangiol. 27:463 (1979).

    PubMed  CAS  Google Scholar 

  37. P. Mayer, J. L. Elghozi and J. P. Grünfield, The physiological basis of the treatment of arterial hypertension. Nouv. Presse Med. 8:2325 (1979).

    Google Scholar 

  38. F. Messerly, J. De Carvalho, B. Christie and B. Fröhlich, Systemic and regional haemodynamics in low, normal and high cardiac output borderline hypertension. Circulation 58:441 (1978).

    Article  Google Scholar 

  39. J. Metha and J. N. Cohn, Haemodynamic effects of labetalol, an alpha and beta-adrenoceptor blocking agent, in hypertensive subjects. Circulation 55:370 (1977).

    Article  Google Scholar 

  40. C. Alicandri, E. Agabiti-Rosci, R. Fariello, L. Corea and B. Muiesan, Effetti emodinamici della somministrazione acuta e cronica del labetalolo nell’ipertensione arteriosa. in: “Atti Convegno Venezia”, p.31 (1978).

    Google Scholar 

  41. K. D. Boch, P. Merguet and V. H. Heimsoth, Effect of Clonidine on regional blood flow and its use in the treatment of hypertension, in: “Hypertension: Mechanisms and Management”, G. Onesti, K.E. Kim and J.A. Mayer eds., Grune and Stratton Inc. p.395 New York, (1973).

    Google Scholar 

  42. L. H. Opie, Drugs and the heart. III Calcium antagonist. Lancet 8172:806 (1980).

    Article  Google Scholar 

  43. W. A. Pettinger, Clonidine a new antihypertensive drug. New. Engl. J. Med., 293:1179 (1975).

    Article  PubMed  CAS  Google Scholar 

  44. G. Thomas, T. G. Pickering, H. John and P. Laragh, Auto-regulation as a factor in peripheral resistance and flow: clinical implications for analysis of high blood pressure (editorial). Am.J.Med. 68:801 (1980).

    Article  Google Scholar 

  45. A. Pinto, La semeiotica strumentale delle arteriopatie obliteranti degli arti inferiori. Coliana di quaderni monografici a cura di E. Massari. in: “Patologia arteriosa distrettuale”, E.S.I. Redaz. Stampa Medica.

    Google Scholar 

  46. B. N. C. Pichard, Beta-adrenoceptor blocking agents in the management of hypertension

    Google Scholar 

  47. L. E. Ramsay, Intermittent claudication in hypertensive men. Journal of the Royal College of Physicians of London 13:100 (1979).

    PubMed  CAS  Google Scholar 

  48. J. L. Reid, H. J. Dargie and C. T. Dollery, Clonidine withdrawal in hypertension. Lancet 2:1171 (1977).

    Article  Google Scholar 

  49. D. A. Richards and E. P. Wooding, The effects of oral AH 5158, a combined alpha and beta-adrenoceptor antagonist in healthy volunteers. Br. J. Clin. Pharmacol. 1:505 (1974).

    Article  PubMed  CAS  Google Scholar 

  50. A. Simon, B. Levy, Y. Weiss, M. Kheder and J. Levenson, Arterial compliance in permanent essential hypertension. Angiology 29:402 (1978).

    Article  PubMed  CAS  Google Scholar 

  51. A. Simon, M. A. Safar, J. Levenson, A. Kheder and B. Levy, Systolic hypertension: haemodynamic mechanism and choice of anti-hypertensive treatment. Am. J. Cardiol. 44:505 (1979).

    Article  PubMed  CAS  Google Scholar 

  52. J. Stamler, Prevenzione primaria e secondaria delle malattie aterosclerotiche. in: “Arteriosclerosi”, Vol.11, R. Paoletti and CR. Sirtori (Coord.), Ambrosiana, Milano, (1977).

    Google Scholar 

  53. R. Stamler, J. Stamler, W. F. Riedlinger, G. Algera and R. H. Roberts, Family (parental) history and prevalence of hypertension. Results of a nationwide screening program. J.A.M.A. 241:43 (1979).

    Article  PubMed  CAS  Google Scholar 

  54. A. Strano, S. Novo, G. Davi, A. Pinto and R. P. Riolo, Aspetti epidemiologici delle arteriopatie degli arti. in: “Giornate Angiologiche Fiorentine”, Firenze 14 Giugno (1979).

    Google Scholar 

  55. A. Strano, Fattori emodinamici nell’aterosclerosi. in: “Aterosclerosi: problemi di patologia e terapia”. Incontri con i medici 1977–1979, a cura della Direzione Medica Janssen.

    Google Scholar 

  56. A. Takeshita and A. L. Mark, Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hipertension 2:610 (1980).

    Article  CAS  Google Scholar 

  57. P. A. Van Zwieten, The central action of antihypertensive drugs, mediated via central alpha-receptors. J. Pharm. Pharmaco1. 25:89 (1973).

    Google Scholar 

  58. J. K. Vyden, J. Thorner, K. Nagasewa, T. Takano, M. F. Groseth-Dittrich, R. Perlow and M. J. Swen, Metabolic and cardiovascular abnormalities in patients with peripheral arterial disease. Am. Heart J. 90:703 (1975).

    Article  PubMed  CAS  Google Scholar 

  59. P. Weidmann, R. De Chatle, W. H. Ziegler, J. Flammer and F. Reubi, Alpha and beta-adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and catecholamine excretion. Am. J. Cardiol. 41:570 (1978).

    Article  PubMed  CAS  Google Scholar 

  60. M. J. Wendeburg, Prolonged treatment of high renin hypertension with a converting enzyme inhibitor. Br. Med. J. 2:866 (1978).

    Article  Google Scholar 

  61. L. Werko, Vascular adaptation to long term blood pressure reduction (Letter). Acta Med.Scand. 207:207 (1980).

    PubMed  CAS  Google Scholar 

  62. A. Zanghetti, Overview of cardiovascular reflexes in hypertension. Am. J. Cardiol. 44:912 (1979).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Pinto, A. et al. (1984). Effects of Antihypertensive Treatment on Peripheral Flow of the Lower Limbs. In: Strano, A. (eds) Thrombosis and Cardiovascular Disease. Advances in Experimental Medicine and Biology, vol 164. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8616-2_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8616-2_29

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8618-6

  • Online ISBN: 978-1-4684-8616-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics